 |
Previous Article | Next Article 
Journal of Neuroscience, Vol 12, 1668-1678, Copyright © 1992 by Society for Neuroscience
Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors
DM Araujo and CW Cotman
Department of Psychobiology, University of California, Irvine 92717.
The present study characterizes whether basic fibroblast growth factor
(bFGF) is present and released from astroglia, microglia, and hippocampal
neurons in vitro. For cell content, bFGF-like immunoreactivity (IR) of cell
extracts was measured, whereas release was determined by assessing the
levels of bFGF-like IR in media. In addition, the effects of lymphokines
and trophic factors that are known to be released from these cells on bFGF
release were examined. For all three cell types, bFGF-like IR in extracts
of cell lysates was detectable. In addition, media content was highest in
astroglial cultures and lowest in neuronal cultures. Although bFGF-like IR
of neuronal and microglial media appeared to increase with time in culture,
this was likely due to significant astroglial proliferation. Thus, notable
levels of bFGF are released by astroglia in vitro. In astroglia, bFGF
release was enhanced by interleukin-1 (IL-1), IL-6, and epidermal growth
factor (EGF), but not by other lymphokines or NGF. In contrast, bFGF in
microglial media was reduced by IL-3, EGF, and NGF, but slightly augmented
by gamma-interferon (IFN); other lymphokines were ineffective. In addition,
no effects were seen in the neuronal cultures. It is likely that the bFGF
found in glial media interacts with bFGF receptors since in both glial and
neuronal cell types, a single class of low-capacity (Bmax), high-affinity
(Kd) bFGF binding sites was evident. The possibility that endogenous bFGF
acts as an autocrine factor for astroglia was further supported by
experiments that tested the mitogenic effects of exogenous bFGF on glial
cells. bFGF significantly enhanced 3H-thymidine uptake into astroglial, but
not microglial, cells in vitro. Thus, the present study demonstrates that a
complex regulation of glial bFGF release by astroglia and microglia occurs
in vitro. Moreover, the results are consistent with an autocrine role for
bFGF in astroglial cultures.
This article has been cited by other articles:

|
 |

|
 |
 
S. Dallas, D. S. Miller, and R. Bendayan
Multidrug resistance-associated proteins: expression and function in the central nervous system.
Pharmacol. Rev.,
June 1, 2006;
58(2):
140 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Y. S. Oh, A. Denninger, J. S. Colvin, A. Vyas, S. Tole, D. M. Ornitz, and R. Bansal
Fibroblast Growth Factor Receptor 3 Signaling Regulates the Onset of Oligodendrocyte Terminal Differentiation
J. Neurosci.,
February 1, 2003;
23(3):
883 - 894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Harada, C. Harada, S. Kohsaka, E. Wada, K. Yoshida, S. Ohno, H. Mamada, K. Tanaka, L. F. Parada, and K. Wada
Microglia-Muller Glia Cell Interactions Control Neurotrophic Factor Production during Light-Induced Retinal Degeneration
J. Neurosci.,
November 1, 2002;
22(21):
9228 - 9236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Numakawa, D. Yokomaku, K. Kiyosue, N. Adachi, T. Matsumoto, Y. Numakawa, T. Taguchi, H. Hatanaka, and M. Yamada
Basic Fibroblast Growth Factor Evokes a Rapid Glutamate Release through Activation of the MAPK Pathway in Cultured Cortical Neurons*
J. Biol. Chem.,
August 2, 2002;
277(32):
28861 - 28869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Basu, J. K. Krady, M. O'Malley, S. D. Styren, S. T. DeKosky, and S. W. Levison
The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury
J. Neurosci.,
July 15, 2002;
22(14):
6071 - 6082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lee, S. Dallas, M. Hong, and R. Bendayan
Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations
Pharmacol. Rev.,
December 1, 2001;
53(4):
569 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Mason, K. Suzuki, D. D. Chaplin, and G. K. Matsushima
Interleukin-1{beta} Promotes Repair of the CNS
J. Neurosci.,
September 15, 2001;
21(18):
7046 - 7052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Noda, H. Nakanishi, J. Nabekura, and N. Akaike
AMPA-Kainate Subtypes of Glutamate Receptor in Rat Cerebral Microglia
J. Neurosci.,
January 1, 2000;
20(1):
251 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ho and M. Blum
Induction of Interleukin-1 Associated with Compensatory Dopaminergic Sprouting in the Denervated Striatum of Young Mice: Model of Aging and Neurodegenerative Disease
J. Neurosci.,
August 1, 1998;
18(15):
5614 - 5629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Moffett, E. Kratz, J. Myers, E. K. Stachowiak, R. Z. Florkiewicz, and M. K. Stachowiak
Transcriptional Regulation of Fibroblast Growth Factor-2 Expression in Human Astrocytes: Implications for Cell Plasticity
Mol. Biol. Cell,
August 1, 1998;
9(8):
2269 - 2285.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Monsonego, Y. Shani, I. Friedmann, Y. Paas, O. Eizenberg, and M. Schwartz
Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes
J. Biol. Chem.,
February 7, 1997;
272(6):
3724 - 3732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yano, K. Fukunaga, M. Takiguchi, Y. Ushio, M. Mori, and E. Miyamoto
Regulation of CCAAT/Enhancer-binding Protein Family Members by Stimulation of Glutamate Receptors in Cultured Rat Cortical Astrocytes
J. Biol. Chem.,
September 20, 1996;
271(38):
23520 - 23527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gard, M. Burrell, S. Pfeiffer, J. Rudge, and W. Williams
Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein
Development,
January 7, 1995;
121(7):
2187 - 2197.
[Abstract]
[PDF]
|
 |
|
|

|